Zobrazeno 1 - 3
of 3
pro vyhledávání: '"cost‐efective"'
Autor:
Ernesto Pérez‐Persona, Laida Cuevas Palomares, Ariane Unamunzaga Cilaurren, Xabier Gutiérrez López de Ocáriz, Buenaventura Buendía Ureña, Ana Vega González de Viñaspre, Begoña Benito Ibarrondo, María Carmen Molinillo Fernández, Ana Cordero Osúa, Beatriz Benítez Delgado, Juan José García Albás, Miguel Ángel Andrés Moralejo, José María Guinea de Castro
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 1196-1199 (2023)
Abstract In this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for patients, and reduce the day‐care hospital stays.
Externí odkaz:
https://doaj.org/article/3f5a1809b6f349108a18f7d0cc44f007
Publikováno v:
Journal of Forestry Research 32 (2021): 1351–1359. doi:10.1007/s11676-021-01327-7
info:cnr-pdr/source/autori:Sicard P.; Hoshika Y.; Carrari E.; De Marco A.; Paoletti E./titolo:Testing visible ozone injury within a Light Exposed Sampling Site as a proxy for ozone risk assessment for European forests/doi:10.1007%2Fs11676-021-01327-7/rivista:Journal of Forestry Research/anno:2021/pagina_da:1351/pagina_a:1359/intervallo_pagine:1351–1359/volume:32
info:cnr-pdr/source/autori:Sicard P.; Hoshika Y.; Carrari E.; De Marco A.; Paoletti E./titolo:Testing visible ozone injury within a Light Exposed Sampling Site as a proxy for ozone risk assessment for European forests/doi:10.1007%2Fs11676-021-01327-7/rivista:Journal of Forestry Research/anno:2021/pagina_da:1351/pagina_a:1359/intervallo_pagine:1351–1359/volume:32
Biologically meaningful and cost-effective indicators are needed for assessing and monitoring the impacts of tropospheric ozone (O3) on vegetation and are required in Europe by the National Emission Ceilings Directive (2016). However, a clear underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf11ca5d40c9849ee3a9ad7cba62bd20
Autor:
Pérez-Persona E; Department of Haematology Complejo Hospitalario de Navarra Pamplona Spain., Cuevas Palomares L; Bioaraba (Onco-Haematology Group) Vitoria-Gasteiz Spain.; Osakidetza (OSI Araba) Hospital Universitario de Álava (Department of Haematology) Vitoria-Gasteiz Spain., Unamunzaga Cilaurren A; Bioaraba (Onco-Haematology Group) Vitoria-Gasteiz Spain., Gutiérrez López de Ocáriz X; Bioaraba (Onco-Haematology Group) Vitoria-Gasteiz Spain., Buendía Ureña B; Bioaraba (Onco-Haematology Group) Vitoria-Gasteiz Spain., Vega González de Viñaspre A; Bioaraba (Onco-Haematology Group) Vitoria-Gasteiz Spain., Benito Ibarrondo B; Osakidetza (OSI Araba) Hospital Universitario de Álava (Day-care Unit) Vitoria-Gasteiz Spain., Molinillo Fernández MC; Osakidetza (OSI Araba) Hospital Universitario de Álava (Day-care Unit) Vitoria-Gasteiz Spain., Cordero Osúa A; Osakidetza (OSI Araba) Hospital Universitario de Álava (Day-care Unit) Vitoria-Gasteiz Spain., Benítez Delgado B; Osakidetza (OSI Araba) Hospital Universitario de Álava (Day-care Unit) Vitoria-Gasteiz Spain., García Albás JJ; Osakidetza (OSI Araba) Hospital Universitario de Álava (Department of Pharmacy) Vitoria-Gasteiz Spain., Andrés Moralejo MÁ; Osakidetza (OSI Araba) Hospital Universitario de Álava (Department of Pharmacy) Vitoria-Gasteiz Spain., Guinea de Castro JM; Bioaraba (Onco-Haematology Group) Vitoria-Gasteiz Spain.
Publikováno v:
EJHaem [EJHaem] 2023 Oct 17; Vol. 4 (4), pp. 1196-1199. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).